Michael H. Berrendorf

BodyTel is a German based company that specializes in telemedical monitoring and management systems for chronic diseases, particularly diabetes. They combine their knowledge in telecommunications, internet and medical technology to create new products and services for the changing needs of global health. BodyTel was incorporated in 2006 and is based in Bad Wildungen/Nordhessen, Germany. Not treated properly, chronic diseases like diabetes can cause serious problems such as kidney failure, lower limb amputations, blindness, heart disease, strokes and nerve damage. Proper monitoring and immediate and accurate patient data is key in managing the condition and preventing further complications that could be costly to managed care plans. The BodyTel system is a completely new approach to effective patient treatment that consists of several components used together in an integrated process. These components are Bluetooth wireless technology enabled meters (blood glucose meter, blood pressure device, weight scales), a Java application for Bluetooth wireless technology and internet enabled cell phones and a secure online database, with graphing and archiving capabilities.

Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.

BodyTel Scientific, Inc. engaged in telemedical monitoring and management systems for chronic diseases, particularly diabetes. The company was founded by Stefan Schraps on April 4, 2005 and was headquartered in New York, NY.